Clinical Trials

Search our database by keywords, interventions, and study design parameters.

Trials in SPOTRIAS Network
Conditions
Interventions
Study Design
Eligibility
Other Criteria
Results available

Additional Filters to Refine your Search Down_arrow_icon

Hide Advanced Filter Options Up_arrow_icon

Name Acronym Phase Status
Prevention of vasospasm in subarachnoid hemorrhage N/A Completed_status_icon
Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in stroke prevention N/A Completed_status_icon
Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid N/A Completed_status_icon
Tranexamic acid in subarachnoid hemorrhage N/A Completed_status_icon
Early heparin therapy in patients with spontaneous intracerebral hemorrhage N/A Completed_status_icon
Pentoxifylline and antiaggregants in recent transient ischemic attacks N/A Completed_status_icon
Intravenous nimodipine and early aneurysm surgery N/A Completed_status_icon
Controlled trial of nimodipine in subarachnoid hemorrhage N/A Completed_status_icon
Antifibrinolytic treatment in subarachnoid hemorrhage N/A Completed_status_icon
Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage N/A Completed_status_icon
Nizofenone administration in subarachnoid hemorrhage N/A Completed_status_icon
Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage 2 Completed_status_icon
British aneurysm nimodipine after subarachnoid hemorrhage N/A Completed_status_icon
Nimodipine in poor-grade aneurysm patients N/A Completed_status_icon
Randomized, double-blind, placebo-controlled trial of tirilazad mesylate: a cooperative study in Europe, Australia, and New Zealand N/A Completed_status_icon
Aspirin in Transient Ischemic Attacks AITIA N/A Completed_status_icon
Danish Cooperative Study N/A Completed_status_icon
Randomized, double-blind, placebo-controlled trial of tirilazad mesylate in subarachnoid hemorrhage: cooperative study in North America N/A Completed_status_icon
Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage N/A Completed_status_icon
Epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage N/A Completed_status_icon
Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage N/A Completed_status_icon
Tranexamic acid in the preoperative management of ruptured intracranial aneurysms N/A Completed_status_icon
Hemodilution therapy in acute ischaemic stroke N/A Completed_status_icon
Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid N/A Completed_status_icon
Prolonged antifibrinolysis in the treatment of ruptured intracranial aneurysms N/A Completed_status_icon
High-dose intravenous hydrocortisone in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage N/A Completed_status_icon
Effect of citicoline on lesion volume in acute stroke Citicoline 010 2 Completed_status_icon
Pentoxifylline versus conventional antiaggregants in secondary stroke prevention N/A Completed_status_icon
Controlled trial of combined urokinase and dextran sulfate in acute cerebral infarction N/A Completed_status_icon
Therapy impact on functional outcome in a controlled trial of stroke rehabilitation N/A Completed_status_icon
Displaying studies 4651 - 4680 of 4776 in total